Replimune Group, Inc.
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against canc…
Biotechnology
US, Woburn [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Replimune Group, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDReplimune Group, Inc. can't present revenue by segment